Retrospective analysis of malignant salivary gland tumors in Hungarian population between 1987-2006
Keywords:
malignancy, salivary gland, tumor, retrospective analysisAbstract
Aim: In our study 64 cases of malignant salivary gland tumors diagnosed at the Otolaryngology, Head and Neck Surgery Clinic of Pécs University from 1987 to 2006 were analyzed. Patients and Methods: The analysis focused on: total number, relative frequency and incidence of the newly diagnosed cases according to gender, age distribution, location, and histopathology and time distribution in two 10-year-periods. Results: The mean age of patients was 59 years. The overall incidence of malignant salivary gland tumors was 0.73/100,000 inhabitants annually and the male: female incidence rate ratio was 0.93. 81.3%of the tumors arose in the parotid gland, 9.4% in the submandibulary gland and 7.8% in the intraoral minor salivary glands. Adenoid cystic carcinoma was the most frequent histopathological diagnosis with 25% relative frequency followed by mucoepidermoid carcinoma and anaplastic carcinoma with equal relative frequency of 14.1%.We compared two ten year time intervals of the 20 year study period by tumor occurrence, incidence and male: female incidence rate ratio. Conclusions: Our results provide the first epidemiological data on malignant salivary gland tumors in Hungarian population comparing different ethnicities and geographic areas to get deeper insight into the etiology of malignant salivary gland tumor development.
Downloads
Published
Issue
Section
License
OPEN ACCESS
All the articles of the European Journal of Oncology and Environmental Health are published with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/). This means that the author(s) retain copyright, but the content is free to download, distribute and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article.
The articles in the previous edition of the Journal (European Journal of Oncology) are made available online with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/).
Upon submission, author(s) grant the Journal the license to publish their original unpublished work within one year, and the non exclusive right to display, store, copy and reuse the content. The CC-BY Creative Commons attribution license enables anyone to use the publication freely, given appropriate attribution to the author(s) and citing the Journal as the original publisher. The CC-BY Creative Commons attribution license does not apply to third-party materials that display a copyright notice to prohibit copying. Unless the third-party content is also subject to a CC-BY Creative Commons attribution license, or an equally permissive license, the author(s) must comply with any third-party copyright notices.